Czechia vs Romania: The number of people with susceptibility test result for rifampicin
Czechia
89.51
in 2021
Romania
89.23
in 2021
Czechia rank
68th
Romania rank
69th
The number of people with susceptibility test result for rifampicin over time
- Czechia
- Romania
How they compare
Czechia currently reports 89.51 against 89.23 in Romania, a difference of 0.28.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Romania ahead.
Czechia ranks 68th and Romania ranks 69th of 146 countries.
Across the 2 decades both report, Czechia averaged higher in 1 and Romania in 1.
Head to head by decade
| Decade | Czechia | Romania | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 86.46 | 88.79 | 2.33 | Romania |
| 2020s | 87.15 | 86.58 | 0.5721 | Czechia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Czechia or Romania?
- Czechia, at 89.51 against 89.23 in Romania as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Czechia and Romania?
- 0.28, with Czechia ahead.
- How many years of comparable data are there for Czechia and Romania?
- 5 years are reported by both, from 2017 to 2021.
- How do Czechia and Romania rank globally for the number of people with susceptibility test result for rifampicin?
- Czechia ranks 68th and Romania ranks 69th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.